6 months ago
1
The Central Information Commission (CIC) has directed the Department for Promotion of Industry and Internal Trade (DPIIT) to record an affidavit that accusation astir authorities backing extended to COVID-19 vaccine manufacturers during the pandemic was "not available" with it.
Also Read | Vaccines bought archetypal utilizing PM CARES funds outgo Centre more
The absorption was issued portion proceeding a Right to Information (RTI) entreaty filed by Mahavir Singh Sharma, who had sought details of thousands of crores of rupees released by the Union authorities to the Serum Institute of India and Bharat Biotech for the accumulation of COVID-19 vaccines successful 2020 and 2021.
In its reply to the RTI application, DPIIT said the accusation sought was not held by its logistics division.
"With notation to your RTI exertion connected the taxable cited above, the requisite accusation sought is not disposable with the logistics division, DPIIT. Therefore, the requisite accusation whitethorn beryllium treated arsenic 'NIL'," the section had stated. The First Appellate Authority aboriginal upheld this response.
In its order, Information Commissioner Khushwant Singh Sethi noted that the logistics part had intelligibly informed the applicant astir the non-availability of the information.
However, the committee directed the nationalist authorization to formally affirm its basal done an affidavit.
"The responsive is directed to record an affidavit to the committee with a categorical connection that the sought accusation successful the RTI exertion dated October 6, 2023, is not disposable with their nationalist authority," the CIC said.
While observing that the reply fixed by DPIIT was appropriate, the committee said the affidavit was indispensable to spot the department's assertion of non-availability of accusation connected grounds earlier disposing of the appeal.
It directed DPIIT to taxable the affidavit wrong 15 days, some by station and by uploading it connected the CIC's compliance portal, with a transcript besides to beryllium served to the appellant (Mr. Sharma).
In his RTI application, Mr. Sharma had sought the information, "The magnitude of ₹4,500 crore, which was released by the Government of India without slope warrant to Serum Institute and Bharat Biotech during COVID, has been returned to the Government of India on with interest, oregon some institutes delivered the vaccine doses successful lieu of the magnitude taken from the government."
He besides asked for the accusation showing that the "Government of India had received each the doses of the vaccines taken from Serum Institute and Bharat Biotech to combat COVID-19 Pandemic," details of vaccines sent overseas "with the support of the Government of India," and "the implicit details of the magnitude received by some the institutes successful speech for the vaccines from abroad."
The applicant further asked whether "all Indian citizens were administered Covishield and Covaxin vaccines oregon immoderate Indian citizens were near out," the "total magnitude spent by the Government of India connected the acquisition of Covaxin and Covishield," and whether immoderate different Covid-19 vaccines were purchased for Indian citizens.
During the hearing, DPIIT officials maintained that the accusation was not held by their part and that the RTI exertion had primitively been filed with different section (Department of Biotechnology) earlier being transferred to them.
